Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.34) by 2.94 percent. This is a 8.33 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $20.586 million which beat the analyst consensus estimate of $20.432 million by 0.75 percent. This is a 8.66 percent decrease over sales of $22.538 million the same period last year.